2211 — Universal Health International Holding Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$30.04m
- HK$35.00m
- CNY1.30bn
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -267 | -493 | -676 | -188 | -106 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -21.9 | -7.97 | 233 | 18.3 | 26.6 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -43.8 | 49.5 | 227 | 101 | 45.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -309 | -408 | -108 | -42.4 | -18.2 |
Capital Expenditures | -3.36 | -95.7 | -1.9 | -0.101 | -0.061 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 12 | -0.417 | 21.6 | 11.2 | -7.96 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 8.63 | -96.1 | 19.7 | 11.1 | -8.02 |
Financing Cash Flow Items | -0.204 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.204 | 7.08 | -10.2 | 56 | 11.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -301 | -497 | -98.2 | 24.7 | -14.8 |